CollPlant Biotechnologies (CLGN) EBIT Margin Growth (1y) (2018 - 2025)
CollPlant Biotechnologies (CLGN) EBIT Margin Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 3,609.00 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1,536.00 |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -282,683.00 |
| Sep 30, 2025 | 10.90 Mn |
| Jun 30, 2025 | 594.00 |
| Mar 31, 2025 | -433,715.00 |
| Dec 31, 2024 | -72,819.00 |
| Sep 30, 2024 | -11.35 Mn |
| Jun 30, 2024 | 171,373.00 |
| Mar 31, 2024 | 360,464.00 |
| Dec 31, 2023 | 636,709.00 |
| Sep 30, 2023 | 409,907.00 |
| Jun 30, 2023 | 639,665.00 |
| Dec 31, 2022 | -683,497.00 |
| Sep 30, 2022 | -188,908.00 |
| Jun 30, 2022 | -589,764.00 |
| Dec 31, 2021 | -113,583.00 |
| Sep 30, 2021 | -222,770.00 |
| Jun 30, 2021 | -21,083.00 |
| Mar 31, 2021 | 34,944.00 |
| Dec 31, 2020 | 50,007.00 |
| Sep 30, 2020 | 27,499.00 |